Active Controlled Trial of the Safety and Tolerability of MP 03-036 (Astepro 0.15%) in Patients With Perennial Allergic Rhinitis.
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2010
At a glance
- Drugs Azelastine (Primary) ; Mometasone
- Indications Perennial allergic rhinitis
- Focus Adverse reactions
- 25 Jan 2010 New trial record